https://www.selleckchem.com/pr....oducts/Roscovitine.h
09, 95%CI(1.04-1.14) and OR 1.34, 95%CI(1.24-1.44) respectively]. The estimates remained unchanged after adjustment for several confounders (such as maternal age, BMI, parity, prior CS, smoking, occupation and country of birth) and potential covariates (such as delivery mode, polyhydramnion, preterm delivery, labor dystocia and infant birthweight above 4000g). CONCLUSIONS Higher risk for PPH was observed both among women treated with SSRI during pregnancy, as well as women with prior or current psychiatric illness. This article is p
Like
Comment
Share
